Rubraca (rucaparib): restriction of indication

Table of contents

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Medicine name
Rubraca
Active substance
rucaparib camsylate
Therapeutic area (MeSH)
Ovarian Neoplasms
Procedure number
EMEA/H/A-20/1518/C/4272/0033
Regulatory outcome
Variation
DHPC type
  • Referral - Article 20 procedure
  • Restriction of indication
Referral name
Rubraca
Human ATC code
L01XX
Dissemination date
12/08/2022

How useful was this page?

Add your rating